SRS Capital Advisors »

Cartesian Therapeutics shares owned by SRS Capital Advisors

Quarter-by-quarter ownership of Cartesian Therapeutics (RNAC) shares owned by SRS Capital Advisors from 13F filings

Historical chart of SRS Capital Advisors investment in Cartesian Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Cartesian Therapeutics held by SRS Capital Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cartesian Therapeutics by SRS Capital Advisors

Quarter filed Position value Share count Share price at filing
2025-09-30 $1.1k 111 10.23
2024-09-30 $194 12 16.17
2024-06-30 $324 12 27.08

More positions owned by SRS Capital Advisors

Vanguard Index Fds Growth Etf (VOO)
Ishares Tr Ishs 1-5yr Invs (OEF)
First Tr Exchange-traded Wtr Etf (FDL)
American Centy Etf Tr Us Large Cap Vlu (KORP)
Dimensional Etf Trust Intl Core Equity (DFAI)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Apple (AAPL)
Schwab Strategic Tr Us Tips Etf (SCHB)
Microsoft Corporation (MSFT)
First Tr Exchng Traded Fd Vi Smith Opport Fxd (FIXD)
First Tr Exchange Traded Risng Divd Achiv (FXN)
NVIDIA Corporation (NVDA)
First Tr Exch Traded Fd Iii Pfd Secs Inc Etf (FPE)
Spdr S&p 500 Etf Tr Tr Unit
Vanguard Tax-managed Fds Van Ftse Dev Mkt (VEA)

View all positions for SRS Capital Advisors

Top funds holding Cartesian Therapeutics

FMR
BlackRock
Siren
Vanguard Group
MPM Oncology Impact Management
Erste Asset Management GmbH
Geode Capital Management
683 Capital Management
State Street Corporation
Susquehanna International
Northern Trust
Citadel Advisors
GSA Capital Partners
Marshall Wace
Royal Bank of Canada

View all funds holding Cartesian Therapeutics